EnglishRachel Humphrey is a medical oncologist, who is currently serving as Head of Research and Development for TIO Bioventures. She is also a Board Director and Chief Medical Officer of all the TIO Bioventures founded biotech companies, including Treadwell Therapeutics. Dr. Humphrey’s career is notable for, among other things, overall supervision of the (early and late-stage) clinical development of ipilimumab (Yervoy) at BMS and sorafenib (Nexavar) at Bayer. She is also the lead singer and one of the co-founders of the band, The Checkpoints, a blues band made up of luminaries in immuno-oncology, including the Nobel Laureate, Jim Allison, and is featured in the movie “Jim Allison: Breakthrough”, which was released in 2019.
Rachel Humphrey: What cancer immunologists are doing about COVID-19 (IUIS-Frontiers Webinar Series on COVID-19)
What are physicians and scientists seeing in their COVID-19-infected patients and in their own personal scientific explorations? What are the ongoing hypotheses that drive the emerging clinical studies, and what can we say about the rapid evolution of medicine, in light of their ongoing work? Rachel Humphrey will give her insights in the live webinar.
Veranstaltungsdatum
Date: May 4, 2020 Time: 16:00 Europe/Berlin